Recent Comments
- E L on Exclusive: The gender reassignment butchers have taken over my NYU surgery
- LoveKatz67 on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- Truth Clearware on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- EricUniqueUsername on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- ThunderbirdRocket on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
Most Viewed Posts
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,181)
- New treatment paradigm for C. Diff colitis (14,080)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (13,593)
- How the FDA regulates compounding pharmacies (13,245)
- The Healthcare Channel hits 10 (12,176)
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (10,785)
- The new CDC guidelines for prescribing opioid pain pills (8,014)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (7,162)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (6,997)
- The MusiCorps benefit concert 2015 (6,056)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – Policy
Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
The transcript is found here May 19, 2023- by Steven E. Greer, MD
Federal appeals court rules that our federal government violated the First Amendment during the pandemic
September 8, 2023- by Steven Greer (pro se litigator extraordinaire)
Exclusive: The gender reassignment butchers have taken over my NYU surgery
September 5, 2023- by Steven E. Greer, MD Opinion-
Federal Court of Appeals Rules that FDA Overstepped by Restricting Ivermectin Use
September 2, 2023- by Steven E. Greer, MD
Posted in - Generics, - Pharma, CDC, Congress, FDA
Leave a comment
Ivermectin works as an antiviral against SARS-CoV-2 (COVID-19)
Update September 4, 2022- A new peer-reviewed study found that regular use of ivermectin reduced the risk of dying from COVID-19 by 92%.
Posted in - Biotech, - Generics, - Pharma, FDA, Infectious disease
Leave a comment
Ivermectin works against COVID in double blind, randomized, controlled trial
May 2, 2023- by Steven E. Greer, MD A new medical meeting poster shows the results of a double blind, randomized, controlled trial of ivermectin as a therapy for COVID. The drug works very well.
Book: The Pfizer/Moderna mRNA Vaccine (i.e., gene therapy) Toxicity
September 1, 2023- by Sucharit Bhakdi, MD et al
Did the COVID vaccines change the human genome?
May 11, 2023- by Steven E. Greer, MD I was the first person on any large media platform to warn that the COVID vaccines would be hard to sell because they worked by altering our genes. I said this on … Continue reading
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, FDA, Infectious disease, Internal Medicine, Neurology, NIH, Oncology
Leave a comment
Interview with Hélène Banoun about why mRNA “vaccines” should be regulated as gene therapies
July 12, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, Cardiology, CDC, Congress, FDA, Infectious disease, Internal Medicine, Oncology
Leave a comment
Interview with drug trials expert Sasha Latypova on how the COVID vaccine approvals were a sham
July 7, 2023- by Steven E. Greer, MD
Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, FDA, Infectious disease, NIH
Leave a comment
Steven E. Greer MD: A discussion with Bill O’Reilly about radiation risks
April 1, 2011- A discussion with Bill O’Reilly about radiation risks from the Fukushima nuclear meltdowns and the fallout hitting the U.S. and entire globe.
Posted in - Policy, Congress, NYU, Ohio State, Oncology
Leave a comment
Rudy Giuliani interviews Steven E. Greer, MD on WABC radio- May 6, 2020
May 6, 2020
Posted in - Opinion, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, NIH
Leave a comment
Steven E. Greer, MD on OANN discussing virus therapies
April 16, 2020
The Miami Summit on Healthcare Spending Reduction
June 29, 2010 Produced and interviewed by Steven Greer, MD The Healthcare Channel and The University of Miami Health System hosted a roundtable discussion
Posted in - Policy, CMS, Congress, Univ Miami
Leave a comment
FDA CDER Director on Benlysta for lupus and adaptive clinical trials.
July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,
Posted in - Biotech, - Pharma, FDA, Rheumatology
Leave a comment
The FDA pathway for biosimilar drug approvals
March 26, 2015- Interviewed by Steven E. Greer,
Posted in - Biotech, - Generics, FDA
Leave a comment
WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020
May 21, 2020- by Steven E. Greer, MD In this segment,
How to establish a face transplant team
Update December 1, 2018- Dr. Rodriguez and his team of at least 100 surgeons, psychiatrists, social
Posted in - Policy, NYU, Plastic surgery
Leave a comment